Tanke Biosciences Corp — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$28.6M

Net Income/Loss (FY2012)

-$229.0K

Total Assets (FY2012)

$28.8M

Total Equity (FY2012)

$15.9M

Cash Flows from Operating Activities (FY2012)

-$1.2M

Source: Tanke Biosciences Corp 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.